Pfizer (PFE)1Q Earnings and Revenue Beat on Cancer Drug, Vaccine Sales

Shares of Pfizer Inc. (PFE) were trading up +0.75 or +2.29 percent to $33.55 per share in Tuesday's premarket after the company reported better than expected earnings and revenue for its fiscal first quarter earlier this morning. Pfizer stock closed at $32.90, up +0.09 or +0.28 percent in Monday's regular trading session. Stock Analysis Incorporated ... READ MORE Read the rest of Pfizer (PFE)1Q Earnings and Revenue Beat on Cancer Drug, Vaccine Sales at InvestorGuide.com .